Brainstorm Cell Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BCLI and buy or sell other stocks, ETFs, and their options commission-free!

About BCLI

Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. 

CEO
Chaim Lebovits
CEOChaim Lebovits
Employees
29
Employees29
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2000
Founded2000
Employees
29
Employees29

BCLI Key Statistics

Market cap
54.03M
Market cap54.03M
Price-Earnings ratio
-15.25
Price-Earnings ratio-15.25
Dividend yield
Dividend yield
Average volume
385.89K
Average volume385.89K
High today
$0.71
High today$0.71
Low today
$0.6301
Low today$0.6301
Open price
$0.71
Open price$0.71
Volume
20.48K
Volume20.48K
52 Week high
$0.7927
52 Week high$0.7927
52 Week low
$0.134
52 Week low$0.134

People also own

Based on the portfolios of people who own BCLI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.